Opus Genetics, Inc. (IRD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Opus Genetics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -25.22x | -0.55x | -2.79x | 1.44x | -0.34x | -0.24x |
| P/B Ratio | 81.49x | 4.73x | 0.56x | 0.56x | 0.86x | -0.45x |
| P/S Ratio | 88.10x | 2.89x | 1.46x | 0.65x | 32.53x | 0.00x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% |
| Operating Margin | -271.9% | -564.7% | -55.5% | 45.7% | -3854.8% | 0.0% |
| Net Margin | -349.3% | -523.4% | -52.4% | 44.9% | -9625.3% | 0.0% |
| EBITDA Margin | -338.6% | -523.3% | -52.3% | 45.7% | -9624.3% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.43x | 3.24x | 13.35x | 17.79x | 6.76x | 5.55x |
| Quick Ratio | 6.43x | 3.24x | 13.35x | 17.79x | 6.76x | 5.55x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.00x |
YoY = year-over-year change. Source: FMP..